Publicaciones en colaboración con investigadores/as de University of Paris-Sorbonne (4)

2020

  1. PARP inhibitors in ovarian cancer

    New England Journal of Medicine

2017

  1. Safety and efficacy of single-agent bevacizumab-containing therapy in elderly patients with platinum-resistant recurrent ovarian cancer: Subgroup analysis of the randomised phase III AURELIA trial

    Gynecologic Oncology, Vol. 144, Núm. 1, pp. 65-71

2016

  1. Current perspectives on recommendations for BRCA genetic testing in ovarian cancer patients

    European Journal of Cancer, Vol. 69, pp. 127-134

2014

  1. Gynecologic cancer intergroup (GCIG) consensus review for squamous cell carcinoma of the ovary

    International Journal of Gynecological Cancer, Vol. 24, Núm. 9, pp. S26-S29